Neurometrix Inc
(NURO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,428 | 922 | 1,607 | 1,260 | 1,732 |
| Marketable Securities | 11,667 | 13,913 | 14,823 | 16,339 | 16,265 |
| Receivables | 193 | 149 | 281 | 470 | 519 |
| Inventories | 1,348 | 1,430 | 1,450 | 1,471 | 1,559 |
| TOTAL | $15,014 | $16,796 | $18,477 | $20,152 | $20,854 |
| Non-Current Assets | |||||
| PPE Net | 199 | 219 | 244 | 269 | 293 |
| Other Non-Current Assets | 111 | 174 | 210 | 244 | 277 |
| TOTAL | $311 | $393 | $453 | $512 | $570 |
| Total Assets | $15,324 | $17,189 | $18,930 | $20,664 | $21,424 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 363 | 348 | 314 | 145 | 216 |
| Accrued Expenses | 542 | 720 | 1,127 | 1,554 | 877 |
| TOTAL | $1,013 | $1,210 | $1,590 | $1,847 | $1,241 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 28 | 61 | 93 |
| TOTAL | $N/A | $N/A | $28 | $61 | $93 |
| Total Liabilities | $1,013 | $1,210 | $1,618 | $1,908 | $1,333 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,060 | 2,043 | 2,026 | 2,011 | 1,987 |
| Retained earnings | -217,915 | -216,135 | -214,627 | -213,139 | -210,109 |
| Other shareholders' equity | 61 | 84 | 112 | 247 | 240 |
| TOTAL | $14,312 | $15,979 | $17,312 | $18,756 | $20,091 |
| Total Liabilities And Equity | $15,324 | $17,189 | $18,930 | $20,664 | $21,424 |